On December 20, 2024, Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity. AASM.org Among persons with moderate-to-severe obstructive sleep apnea and obesity, tirzepatide reduced the AHI, body weight, hypoxic burden, hsCRP concentration, and systolic blood pressure and improved sleep-related patient-reported outcomes. NIH study Can the makers of these new weight loss medications really claim to treat and cure Obstructive Sleep Apnea (OSA)
This is where modern peptide research becomes truly exciting
Conclusions Antioxidant supplementation appears safe and significantly improves erectile function in men with ED, particularly those with more severe symptoms
Many folks in Erie, PA, are finding success with these therapies
If that 10 mg blend is a 1:1 CJC-1295 + Ipamorelin vial, each 50 mcg total unit represents about 25 mcg CJC-1295 and 25 mcg Ipamorelin
Aflatoxin contamination of corn under different agro-environmental conditions and biocontrol applications